Venous Thrombosis during Spaceflight

Abstract

An obstructive jugular-vein thrombosis developed in an astronaut 2 months into a 6-month space mission, a clinical scenario with no evidence base to support the choice of a management approach. The thrombosis was managed with enoxaparin, followed by apixaban, which was discontinued 4 days before Earth landing. No adverse sequelae were noted.